about
Usefulness of serum leucine-rich alpha-2 glycoprotein as a disease activity biomarker in patients with rheumatoid arthritis.Clinical and Genetic Features of Korean Patients with Recurrent Fever and Multi-System Inflammation without Infectious or Autoimmune EvidenceSOCS1 suppresses IL-1β-induced C/EBPβ expression via transcriptional regulation in human chondrocytes.The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis.Increased serum interleukin-32 levels in patients with Behçet's disease.The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis.PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytesCirculating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid ArthritisInfluence of androgen deprivation therapy on serum urate levels in patients with prostate cancer: A retrospective observational studyDiffuse large B-cell lymphoma involving the left sternoclavicular joint mimicking rheumatoid arthritis flare: a case-based reviewAutoantibody Biomarkers in Rheumatic DiseasesClinical features and risk factors for gout attacks during anti-tuberculosis treatment: A case-control study in South KoreaAssociation between socioeconomic status and comorbidities among patients with rheumatoid arthritis: results of a nationwide cross-sectional surveyPerformance of the 2015 American College of Rheumatology/European League against Rheumatism Classification Criteria for Gout in Korean Patients with Acute ArthritisNovel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patientsRisk prediction model in rheumatoid arthritis-associated interstitial lung diseaseSeasonal Variations and Associated Factors of Gout Attacks: a Prospective Multicenter Study in Korea
P50
Q34208244-D91BBF57-02B5-452F-96E7-AC6317A4F788Q36509924-C27FF9F0-3C0E-4C5A-94DE-22290F9E6F6DQ37057703-033F66C8-6F0A-43E4-8BDB-574D564637A1Q37944499-369F98CC-D354-406C-A7A8-14E6C72F5F80Q48318960-1A8DE8A4-A2A8-4FEB-B9C4-F4429E704C12Q51633316-23F6623C-6476-48C9-A38E-39566C57F047Q59352852-72100476-5B8B-4E06-9213-38B9DB090CE2Q59806580-B39E0A79-5BFC-49C6-8665-D3EDE41ED89EQ60301772-B2BFC114-A9C8-4681-AE6D-A5725A401576Q89612257-BE650BB3-7F32-4626-8D73-81122249B6CBQ89835389-BAC4FFFC-6049-4FB5-9AE5-6AB3DE6E62E6Q90157205-5E45C6DF-BAF0-4259-88A9-68B03834D58BQ92500539-477A5CEC-6F92-40DB-9FB5-CCF136BC47D1Q92578803-C0704A0E-9BBF-4C52-ACE6-0EB4C0E37EDCQ92882890-65AEE10C-E91C-4B5D-B153-9F664E5A82D4Q95644690-A2C0F5C1-2336-44E8-BC39-33FF444575E8Q95657447-9D396819-E05E-4153-AD74-FF2EF48640A9
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
հետազոտող
@hy
研究者
@zh
name
You-Jung Ha
@ast
You-Jung Ha
@en
You-Jung Ha
@es
You-Jung Ha
@nl
type
label
You-Jung Ha
@ast
You-Jung Ha
@en
You-Jung Ha
@es
You-Jung Ha
@nl
prefLabel
You-Jung Ha
@ast
You-Jung Ha
@en
You-Jung Ha
@es
You-Jung Ha
@nl
P31
P496
0000-0001-6107-9523